GlobeNewswire

HAProxy Technologies Announces Improvements to Performance, Management, and Security for Enterprises

Dela

HAProxy Enterprise Edition 1.8r1 Adds HTTP/2, Dynamic Scaling, WAF, and Other Key Enterprise Features

BOSTON, May 02, 2018 (GLOBE NEWSWIRE) -- HAProxy Technologies, the company behind the world's fastest and most widely used software load balancer, is announcing the release of HAProxy  Enterprise Edition 1.8r1. HAProxy Enterprise Edition 1.8r1 is built on top of the monumental stable release of HAProxy 1.8 with additional enhancements that help enterprises manage and secure modern application environments across the full spectrum of today's threats.

HAProxy Enterprise Edition 1.8r1 contains a number of powerful improvements in performance and application acceleration such as support for HTTP/2, Multithreading, and Small Object Caching. There are also significant improvements in dynamic capabilities for cloud and microservices environments including Hitless Reloads, DNS for Service Discovery, Server Templates, and improved Runtime API functionality.

"This is the biggest and possibly most anticipated release of HAProxy Enterprise Edition we have ever had," said Willy Tarreau, CTO HAProxy Technologies. "I'm very proud of the whole HAProxy Technologies R&D team as well as the community contributors for their hard work in advancing HAProxy in multiple key areas including fast and secure edge and microservices delivery, while maintaining the proven reliability that it is known for."

HAProxy Enterprise Edition 1.8r1 ships with an enterprise suite which contains administration and security-focused add-ons that have the same level of high performance that users expect from HAProxy. The latest additions include a new Web Application Firewall, Stick Table Aggregator with real time, cluster-wide tracking for improved DDoS attack and bot protection, direct integration with Google reCAPTCHA, Single Sign On (SSO) support, and significant improvements to the Real Time Dashboard.

"As the company behind the world's fastest and most widely used software load balancer, we have been trusted by millions of websites to continually deliver highly secure and reliable products," said Dujko Radovnikovic, CEO HAProxy Technologies. "Our latest release strengthens this trust by providing a powerful set of new features to manage and secure modern applications while maintaining our best-in-class performance and reliability."

"We initially chose HAProxy Enterprise Edition over other software load balancers due to its performance and reliability. Since then we've worked closely with the HAProxy Technologies team to provide feedback and leverage their support. We are very excited to see the 1.8r1 release which not only includes many useful capabilities, but also incorporates many of our own feature requests," said Scott Bruce, Director of Application Architecture, dataxu.

HAProxy 1.8 and HAProxy Enterprise Edition 1.8r1 Key Enhancements:

  • HTTP/2 Support - Support for clients to communicate with the load balancer via the HTTP/2 protocol.

  • Multithreading - Splits processing across multiple threads while sharing the same memory space.

  • HTTP Small Object Caching - Caches small objects in memory.

  • Hitless Reloads - Reloads of HAProxy do not lose any connections for upgrades or changes to the configuration.

  • DNS for Service Discovery - Dynamically scales the number of backend servers by querying the service registry over DNS. Maintains the IP address, port, and weight of the servers within HAProxy.

  • Server Templates - Enables the provisioning of multiple backend servers with a single server line to be filled in during runtime.

  • Improved Runtime API - Gives the ability to pull statistics and information from HAProxy or to dynamically configure it during runtime.

Exclusive HAProxy Enterprise Edition 1.8r1 Key Enhancements:

  • WAF Module - A high-performance Web Application Firewall which supports both whitelist based and blacklist based rulesets, ensuring a very high level of protection for even the most insecure web applications.

  • Stick Table Aggregator - Combines values from stick tables across multiple processes or servers which allows for real time cluster-wide tracking of any characteristic of a request.

  • reCAPTCHA Module - Enables presenting anomalous clients with Google reCAPTCHA v2 challenges which can protect websites from bots and other types of automated threats while letting real users pass through with ease.

  • SSO Module - Enables the implementation of SSO (Single Sign On) on a Microsoft Active Directory domain.

  • Real Time Dashboard - Provides management capabilities and an aggregated view of service activity and status which updates and graphs in real time, with visual alerting when values reach defined thresholds.

For more information on everything new in HAProxy Enterprise Edition 1.8r1, you can watch the on-demand webinar at What's New in HAProxy Enterprise Edition 1.8r1

About HAProxy Enterprise Edition

HAProxy Enterprise Edition is an enterprise-class version of HAProxy that includes a robust and cutting-edge code base, enterprise suite of add-ons, expert support, and professional services. At its core, it incorporates feature backports from the HAProxy development branch for customers who require immediate access to the latest functionality in a hardened version of code.

About HAProxy Technologies

HAProxy Technologies is the company behind HAProxy, the world's fastest and most widely used software load balancer. High-profile websites including Booking.com, GitHub, Reddit, StackOverflow, Tumblr, Vimeo and Yelp choose HAProxy to deliver websites and applications with high availability, performance, and security at any scale. Trusted by leading cloud providers such as Amazon Web Services, Rackspace, Red Hat OpenShift, and OpenStack, HAProxy sets the standard for superior application delivery. HAProxy Technologies is headquartered in Waltham, MA, with offices in France and Croatia. For more information on HAProxy, support, and enterprise solutions, visit: www.haproxy.com. You can also follow @HAProxy on Twitter or visit us on LinkedIn and Facebook for more information about HAProxy.

Media Contact

Company Name: HAProxy Technologies
Email Address: press@haproxy.com Website: www.haproxy.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: HAProxy Technologies via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development delays publication of its Annual Report for 2018 and changes date for the Annual General Meeting26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SWEDEN - 26 April 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that The Board of Directors has decided to delay the publication of its Annual Report for 2018. Karolinska Development has changed the date for the Annual General Meeting to June 26, 2019. The date for publication of the Annual Report for 2018 has been changed from April 26 to April 30, 2019. Karolinska Development has changed the date for the Annual General Meeting from June 4 to June 26, 2019. Notice to the Annual General Meeting will be published in a separate press release. For more information, please contact: Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, CFO, Karolinska Development AB Phone: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TO THE EDITORS About Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investmen

Karolinska Development senarelägger publicering av årsredovisningen för 2018 och meddelar nytt datum för årsstämma26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 26 april 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att styrelsen har beslutat att senarelägga publiceringen av årsredovisningen för 2018. Karolinska Development har ändrat datum för årsstämman till den 26 juni 2019. Publiceringen av årsredovisningen för 2018 flyttas från den 26 april till den 30 april 2019. Karolinska Development har ändrat datum för årsstämman från den 4 juni till den 26 juni 2019. Kallelse till årsstämman kommer att publiceras senare i ett separat pressmeddelande. För ytterligare information, vänligen kontakta: Viktor Drvota, vd, Karolinska Development AB Tel: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, finanschef, Karolinska Development AB Tel: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TILL REDAKTÖRERNA Om Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) är ett nordiskt investmentbolag inom life science. Bolaget fokuserar p

Karolinska Developments portföljbolag Aprea Therapeutics har fått särläkemedelsstatus och snabbspårstatus från FDA för APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 16 april 2019. Karolinska Development AB meddelar idag att portföljbolaget Aprea Therapeutics har av FDA fått särläkemedelsstatus för APR-246 för behandling av patienter med TP53-muterad myelodysplastiskt syndrom (MDS). Dessutom ger FDA bolaget snabbspårstatus (Fast Track Designation), för APR-246 för behandling av MDS. Amerikanska läkemedelsverket, FDA, ger särläkemedelsstatus till läkemedelskandidater för att snabba på utvärderingen och utvecklingen av säkra och effektiva behandlingar av ovanliga sjukdomar. Särläkemedelsstatus ger företag både regulatoriska och kommersiella incitament genom att läkemedlet får marknadsexklusivitet på den amerikanska marknaden i sju år efter marknadsgodkännande samtidigt som företaget får stöd från FDA när det gäller designen av kliniska prövningar, skatteförmåner för kostnader kopplade till kliniska prövningar och avgiftsbefrielse från FDA. FDA:s snabbspår underlättar utvecklingen av läkemedel som är avsedda för att behandla allva

Karolinska Development's portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, April 16, 2019. Karolinska Development's portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes (MDS) having a TP53 mutation. In addition, FDA has also granted Fast Track Designation to APR-246 for treatment of MDS. Orphan Drug Designation is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. after product approval, FDA assistance in clinical trial design, tax credits related to clinical trial expenses, and an exemption from FDA user fees. The FDA's Fast Track program facilitates the development of drugs intended to treat serious conditions and that have the potential to addre

Bergman & Beving AB: Bergman & Beving förvärvar KGC10.4.2019 14:00:00 CESTPressmeddelande

Pressmeddelande Bergman & Beving förvärvar KGC Bergman & Beving har idag tecknat avtal om förvärv av samtliga aktier i KGC Verktyg & Maskiner AB. KGC, med säte i Älvsjö, har i mer än 60 år utvecklat och levererat kvalitetsverktyg och tillbehör för murning och plattsättning i det egna varumärket KGC. Bolaget omsätter cirka 80 MSEK per år, och har 24 anställda. "KGC är ett ledande varumärke med högt anseende hos murare och plattsättare och har en mycket stark ställning på den svenska marknaden", säger Pontus Boman, VD och koncernchef. Tillträde beräknas ske den 1 maj 2019 och förvärvet bedöms ha en marginellt positiv påverkan på Bergman & Bevings resultat per aktie under innevarande räkenskapsår. Stockholm den 10 april 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Pontus Boman, VD & Koncernchef, telefon 010-454 77 00 Peter Schön, CFO, telefon 070-339 89 99 Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 10 april 201

Bergman & Beving AB: Bergman & Beving acquires KGC10.4.2019 14:00:00 CESTPressmeddelande

Press release Bergman & Beving acquires KGC Bergman & Beving has today signed an agreement to acquire all shares in KGC Verktyg & Maskiner AB. KGC, based in Älvsjö, has for more than 60 years developed and delivered quality tools and accessories for bricklayers and tilers in its own brand KGC. The business has a turnover of approximately SEK 80 million per year, and has 24 employees. "KGC is a leading brand with high reputation among bricklayers and tilers and has a very strong position in the Swedish market," says Pontus Boman, President and CEO. The closing is taking effect on 1 May 2019 and the acquisition is expected to have a marginal positive impact on Bergman & Beving's earnings per share during the current fiscal year. Stockholm, 10 April 2019 Bergman & Beving AB (publ) For further information, please contact: Pontus Boman, President & CEO, Tel: +46 10 454 77 00 Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the cont

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum